ReviewHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.

Erica Chilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.